Dr. Mackey is a medical oncologist and Professor Emeritus of Oncology at the University of Alberta. In addition to acting as director and clinical advisor to illumiSonics, Dr. Mackey brings deep MedTech commercialization experience.  He co-founded Pacylex Pharmaceuticals, J2 Endeavours, and SMHeartCard Inc.  As Chair of the Alberta Pre-Phase I Program steering committee, he has a highly skilled team committed to bringing new anticancer therapies into clinical testing (www.prephaseone.com). Dr. Mackey has authored or co-authored more than 300 biomedical peer-reviewed publications.